Ming Zhai

431 total citations
22 papers, 278 citations indexed

About

Ming Zhai is a scholar working on Molecular Biology, Immunology and Surgery. According to data from OpenAlex, Ming Zhai has authored 22 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Immunology and 5 papers in Surgery. Recurrent topics in Ming Zhai's work include Epigenetics and DNA Methylation (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Immune cells in cancer (3 papers). Ming Zhai is often cited by papers focused on Epigenetics and DNA Methylation (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Immune cells in cancer (3 papers). Ming Zhai collaborates with scholars based in China and United States. Ming Zhai's co-authors include Wenhui Peng, Weixia Jian, Yanxi Zeng, Wenxin Kou, Hui He, Jianhui Zhuang, Hong‐Hao Zhou, Peipei Luan, Mark W. Feinberg and Yu Zhang and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Circulation Research.

In The Last Decade

Ming Zhai

18 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Zhai China 10 105 72 55 50 43 22 278
Takatoshi Yamamoto Japan 11 108 1.0× 67 0.9× 44 0.8× 34 0.7× 59 1.4× 21 342
Chittibabu Vatte Saudi Arabia 11 85 0.8× 21 0.3× 42 0.8× 32 0.6× 46 1.1× 38 274
Julia Martínez-Sánchez Spain 9 69 0.7× 57 0.8× 31 0.6× 23 0.5× 19 0.4× 20 233
Dominika Łacheta Poland 5 66 0.6× 69 1.0× 20 0.4× 33 0.7× 39 0.9× 8 279
Urpu Salmenniemi Finland 14 104 1.0× 110 1.5× 49 0.9× 30 0.6× 47 1.1× 40 439
Claire Jones United Kingdom 3 52 0.5× 49 0.7× 42 0.8× 49 1.0× 54 1.3× 9 259
Benjamin E. J. Spurgeon United Kingdom 11 90 0.9× 51 0.7× 37 0.7× 69 1.4× 32 0.7× 23 309
Andrés Carmona Spain 9 172 1.6× 76 1.1× 11 0.2× 42 0.8× 18 0.4× 18 321
Jered Myslinski United States 8 159 1.5× 61 0.8× 15 0.3× 14 0.3× 24 0.6× 11 336

Countries citing papers authored by Ming Zhai

Since Specialization
Citations

This map shows the geographic impact of Ming Zhai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Zhai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Zhai more than expected).

Fields of papers citing papers by Ming Zhai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Zhai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Zhai. The network helps show where Ming Zhai may publish in the future.

Co-authorship network of co-authors of Ming Zhai

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Zhai. A scholar is included among the top collaborators of Ming Zhai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Zhai. Ming Zhai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhai, Ming, Jun Qian, Winona Wu, et al.. (2025). A smooth muscle cell lncRNA controls angiogenesis in chronic limb-threatening ischemia through miR-143-3p/HHIP signaling. Journal of Clinical Investigation. 135(20).
2.
Gao, Ying, Brian Xi, Yang Zhang, et al.. (2025). Gut-brain axis and exosome-mediated communication in postoperative cognitive dysfunction associated with colorectal cancer. Acta Biochimica et Biophysica Sinica.
3.
4.
Zhai, Ming, Zhijun Lei, Yanxi Zeng, et al.. (2024). TREM2 macrophage promotes cardiac repair in myocardial infarction by reprogramming metabolism via SLC25A53. Cell Death and Differentiation. 31(2). 239–253. 46 indexed citations
5.
Kou, Wenxin, Ming Zhai, Yanxi Zeng, et al.. (2023). Loss of TET2 impairs endothelial angiogenesis via downregulating STAT3 target genes. Cell & Bioscience. 13(1). 12–12. 6 indexed citations
6.
Zeng, Yanxi, Ming Zhai, Jianhui Zhuang, et al.. (2023). Endothelial TET2 regulates the white adipose browning and metabolism via fatty acid oxidation in obesity. Redox Biology. 69. 103013–103013. 5 indexed citations
7.
Zeng, Yanxi, et al.. (2023). NLRC3 deficiency promotes hypoxia-induced pulmonary hypertension development via IKK/NF-κB p65/HIF-1α pathway. Experimental Cell Research. 431(2). 113755–113755. 16 indexed citations
8.
Yu, Qing, Wenxin Kou, Ming Zhai, et al.. (2023). Macrophage-Specific NLRC5 Protects From Cardiac Remodeling Through Interaction With HSPA8. JACC Basic to Translational Science. 8(5). 479–496. 16 indexed citations
9.
10.
Zhai, Ming, Peipei Luan, Wenxin Kou, et al.. (2022). Extracellular traps from activated vascular smooth muscle cells drive the progression of atherosclerosis. Nature Communications. 13(1). 7500–7500. 40 indexed citations
11.
12.
Xu, Xu, Peipei Luan, Wenxin Kou, et al.. (2021). The subcellular redistribution of NLRC5 promotes angiogenesis via interacting with STAT3 in endothelial cells. Theranostics. 11(9). 4483–4501. 13 indexed citations
13.
Li, Bo, You Wu, Bingyu Li, et al.. (2021). The Association and Pathogenesis of SERPINA3 in Coronary Artery Disease. Frontiers in Cardiovascular Medicine. 8. 756889–756889. 21 indexed citations
14.
15.
He, Hui, Ji‐Ye Yin, Xi Li, et al.. (2015). Association of ABCB1 polymorphisms with prognostic outcomes of anthracycline and cytarabine in Chinese patients with acute myeloid leukemia. European Journal of Clinical Pharmacology. 71(3). 293–302. 22 indexed citations
16.
Zhai, Ming, Yan Wang, & Min Jiang. (2015). Arg188His polymorphism in the XRCC2 gene and the risk of ovarian cancer: a meta-analysis. Genetics and Molecular Research. 14(3). 10808–10815. 8 indexed citations
17.
He, Hui, Ji‐Ye Yin, Li Xi, et al.. (2014). Association of ABCB1 Polymorphisms With the Efficacy of Ondansetron in Chemotherapy-induced Nausea and Vomiting. Clinical Therapeutics. 36(8). 1242–1252.e2. 33 indexed citations
18.
He, Hui, Ji‐Ye Yin, Xi Li, et al.. (2014). Association of nitric oxide synthase 3 (NOS3) 894 G>T polymorphism with prognostic outcomes of anthracycline in Chinese patients with acute myeloid leukaemia. Clinical and Experimental Pharmacology and Physiology. 41(6). 400–407. 5 indexed citations
19.
20.
Zhao, Yongqiang, Qingyu Wang, Ming Zhai, et al.. (2004). [A multi-center clinical trial of recombinant human thrombopoietin in chronic refractory idiopathic thrombocytopenic purpura].. PubMed. 43(8). 608–10. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Takatoshi Yamamoto Breakdown of academic impact, for papers by Chittibabu Vatte Breakdown of academic impact, for papers by Julia Martínez-Sánchez Breakdown of academic impact, for papers by Dominika Łacheta Breakdown of academic impact, for papers by Urpu Salmenniemi Breakdown of academic impact, for papers by Claire Jones Breakdown of academic impact, for papers by Benjamin E. J. Spurgeon Breakdown of academic impact, for papers by Andrés Carmona Breakdown of academic impact, for papers by Jered Myslinski
Rankless by CCL
2026